Firefly Neuroscience (AIFF) Competitors $1.68 +0.02 (+1.20%) Closing price 05/20/2026 04:00 PM EasternExtended Trading$1.67 -0.01 (-0.65%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AIFF vs. CANG, PODC, DH, CCLD, and AEYEShould you buy Firefly Neuroscience stock or one of its competitors? MarketBeat compares Firefly Neuroscience with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Firefly Neuroscience include Cango (CANG), PodcastOne (PODC), Definitive Healthcare (DH), CareCloud (CCLD), and Audioeye (AEYE). These companies are all part of the "computer software" industry. AIFF vs. CANGAIFF vs. PODCAIFF vs. DHAIFF vs. CCLDAIFF vs. AEYEHow does Firefly Neuroscience compare to Cango?Cango (NYSE:CANG) and Firefly Neuroscience (NASDAQ:AIFF) are both small-cap computer software companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk. Which has more volatility & risk, CANG or AIFF? Cango has a beta of 0.99, indicating that its share price is 1% less volatile than the broader market. Comparatively, Firefly Neuroscience has a beta of 0.6, indicating that its share price is 40% less volatile than the broader market. Does the media refer more to CANG or AIFF? In the previous week, Cango had 12 more articles in the media than Firefly Neuroscience. MarketBeat recorded 13 mentions for Cango and 1 mentions for Firefly Neuroscience. Cango's average media sentiment score of -0.28 beat Firefly Neuroscience's score of -0.47 indicating that Cango is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cango 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Firefly Neuroscience 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is CANG or AIFF more profitable? Cango has a net margin of -83.92% compared to Firefly Neuroscience's net margin of -565.40%. Cango's return on equity of -49.13% beat Firefly Neuroscience's return on equity.Company Net Margins Return on Equity Return on Assets Cango-83.92% -49.13% -24.42% Firefly Neuroscience -565.40%-94.68%-73.51% Which has better earnings & valuation, CANG or AIFF? Firefly Neuroscience has lower revenue, but higher earnings than Cango. Firefly Neuroscience is trading at a lower price-to-earnings ratio than Cango, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCango$688.08M0.13-$621.95M-$2.97N/AFirefly Neuroscience$1.14M22.95-$19.88M-$0.63N/A Do analysts rate CANG or AIFF? Cango presently has a consensus price target of $3.00, suggesting a potential upside of 500.00%. Given Cango's stronger consensus rating and higher possible upside, research analysts plainly believe Cango is more favorable than Firefly Neuroscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cango 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Do institutionals and insiders hold more shares of CANG or AIFF? 4.2% of Cango shares are owned by institutional investors. Comparatively, 5.0% of Firefly Neuroscience shares are owned by institutional investors. 29.1% of Cango shares are owned by company insiders. Comparatively, 6.4% of Firefly Neuroscience shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryCango beats Firefly Neuroscience on 13 of the 17 factors compared between the two stocks.How does Firefly Neuroscience compare to PodcastOne?PodcastOne (NASDAQ:PODC) and Firefly Neuroscience (NASDAQ:AIFF) are both small-cap computer software companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk. Is PODC or AIFF more profitable? PodcastOne has a net margin of -6.22% compared to Firefly Neuroscience's net margin of -565.40%. PodcastOne's return on equity of -24.78% beat Firefly Neuroscience's return on equity.Company Net Margins Return on Equity Return on Assets PodcastOne-6.22% -24.78% -16.46% Firefly Neuroscience -565.40%-94.68%-73.51% Do insiders and institutionals hold more shares of PODC or AIFF? 2.9% of PodcastOne shares are held by institutional investors. Comparatively, 5.0% of Firefly Neuroscience shares are held by institutional investors. 79.4% of PodcastOne shares are held by insiders. Comparatively, 6.4% of Firefly Neuroscience shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has more volatility and risk, PODC or AIFF? PodcastOne has a beta of 1.72, indicating that its share price is 72% more volatile than the broader market. Comparatively, Firefly Neuroscience has a beta of 0.6, indicating that its share price is 40% less volatile than the broader market. Which has higher valuation & earnings, PODC or AIFF? PodcastOne has higher revenue and earnings than Firefly Neuroscience. PodcastOne is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPodcastOne$52.12M2.13-$6.46M-$0.15N/AFirefly Neuroscience$1.14M22.95-$19.88M-$0.63N/A Do analysts rate PODC or AIFF? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PodcastOne 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Does the media refer more to PODC or AIFF? In the previous week, PodcastOne had 9 more articles in the media than Firefly Neuroscience. MarketBeat recorded 10 mentions for PodcastOne and 1 mentions for Firefly Neuroscience. PodcastOne's average media sentiment score of -0.29 beat Firefly Neuroscience's score of -0.47 indicating that PodcastOne is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PodcastOne 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Firefly Neuroscience 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryPodcastOne beats Firefly Neuroscience on 11 of the 14 factors compared between the two stocks.How does Firefly Neuroscience compare to Definitive Healthcare?Definitive Healthcare (NASDAQ:DH) and Firefly Neuroscience (NASDAQ:AIFF) are both small-cap computer software companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, media sentiment, institutional ownership, risk and earnings. Is DH or AIFF more profitable? Definitive Healthcare has a net margin of -76.04% compared to Firefly Neuroscience's net margin of -565.40%. Definitive Healthcare's return on equity of 4.04% beat Firefly Neuroscience's return on equity.Company Net Margins Return on Equity Return on Assets Definitive Healthcare-76.04% 4.04% 1.99% Firefly Neuroscience -565.40%-94.68%-73.51% Do insiders & institutionals hold more shares of DH or AIFF? 98.7% of Definitive Healthcare shares are held by institutional investors. Comparatively, 5.0% of Firefly Neuroscience shares are held by institutional investors. 16.3% of Definitive Healthcare shares are held by company insiders. Comparatively, 6.4% of Firefly Neuroscience shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more risk & volatility, DH or AIFF? Definitive Healthcare has a beta of 1.34, indicating that its stock price is 34% more volatile than the broader market. Comparatively, Firefly Neuroscience has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market. Do analysts rate DH or AIFF? Definitive Healthcare presently has a consensus price target of $2.77, suggesting a potential upside of 221.97%. Given Definitive Healthcare's stronger consensus rating and higher probable upside, equities analysts clearly believe Definitive Healthcare is more favorable than Firefly Neuroscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Definitive Healthcare 3 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.00Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Which has preferable earnings and valuation, DH or AIFF? Firefly Neuroscience has lower revenue, but higher earnings than Definitive Healthcare. Firefly Neuroscience is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDefinitive Healthcare$241.52M0.38-$138.93M-$1.62N/AFirefly Neuroscience$1.14M22.95-$19.88M-$0.63N/A Does the media refer more to DH or AIFF? In the previous week, Definitive Healthcare had 1 more articles in the media than Firefly Neuroscience. MarketBeat recorded 2 mentions for Definitive Healthcare and 1 mentions for Firefly Neuroscience. Definitive Healthcare's average media sentiment score of 0.43 beat Firefly Neuroscience's score of -0.47 indicating that Definitive Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Definitive Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Firefly Neuroscience 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryDefinitive Healthcare beats Firefly Neuroscience on 14 of the 17 factors compared between the two stocks.How does Firefly Neuroscience compare to CareCloud?Firefly Neuroscience (NASDAQ:AIFF) and CareCloud (NASDAQ:CCLD) are both small-cap computer software companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk. Which has more volatility and risk, AIFF or CCLD? Firefly Neuroscience has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market. Comparatively, CareCloud has a beta of 1.6, indicating that its stock price is 60% more volatile than the broader market. Which has better earnings and valuation, AIFF or CCLD? CareCloud has higher revenue and earnings than Firefly Neuroscience. Firefly Neuroscience is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFirefly Neuroscience$1.14M22.95-$19.88M-$0.63N/ACareCloud$120.50M0.83$10.80M$0.1121.27 Do analysts prefer AIFF or CCLD? CareCloud has a consensus target price of $3.25, indicating a potential upside of 38.89%. Given CareCloud's stronger consensus rating and higher possible upside, analysts clearly believe CareCloud is more favorable than Firefly Neuroscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00CareCloud 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the media prefer AIFF or CCLD? In the previous week, CareCloud had 3 more articles in the media than Firefly Neuroscience. MarketBeat recorded 4 mentions for CareCloud and 1 mentions for Firefly Neuroscience. CareCloud's average media sentiment score of 0.40 beat Firefly Neuroscience's score of -0.47 indicating that CareCloud is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Firefly Neuroscience 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CareCloud 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is AIFF or CCLD more profitable? CareCloud has a net margin of 7.87% compared to Firefly Neuroscience's net margin of -565.40%. CareCloud's return on equity of 24.05% beat Firefly Neuroscience's return on equity.Company Net Margins Return on Equity Return on Assets Firefly Neuroscience-565.40% -94.68% -73.51% CareCloud 7.87%24.05%16.38% Do institutionals and insiders believe in AIFF or CCLD? 5.0% of Firefly Neuroscience shares are held by institutional investors. Comparatively, 10.2% of CareCloud shares are held by institutional investors. 6.4% of Firefly Neuroscience shares are held by company insiders. Comparatively, 14.8% of CareCloud shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryCareCloud beats Firefly Neuroscience on 15 of the 16 factors compared between the two stocks.How does Firefly Neuroscience compare to Audioeye?Audioeye (NASDAQ:AEYE) and Firefly Neuroscience (NASDAQ:AIFF) are both small-cap computer software companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends. Do insiders and institutionals believe in AEYE or AIFF? 51.1% of Audioeye shares are owned by institutional investors. Comparatively, 5.0% of Firefly Neuroscience shares are owned by institutional investors. 28.8% of Audioeye shares are owned by insiders. Comparatively, 6.4% of Firefly Neuroscience shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media favor AEYE or AIFF? In the previous week, Audioeye had 4 more articles in the media than Firefly Neuroscience. MarketBeat recorded 5 mentions for Audioeye and 1 mentions for Firefly Neuroscience. Audioeye's average media sentiment score of 0.09 beat Firefly Neuroscience's score of -0.47 indicating that Audioeye is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Audioeye 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Firefly Neuroscience 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is AEYE or AIFF more profitable? Audioeye has a net margin of -9.05% compared to Firefly Neuroscience's net margin of -565.40%. Audioeye's return on equity of 71.24% beat Firefly Neuroscience's return on equity.Company Net Margins Return on Equity Return on Assets Audioeye-9.05% 71.24% 11.35% Firefly Neuroscience -565.40%-94.68%-73.51% Which has more risk and volatility, AEYE or AIFF? Audioeye has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, Firefly Neuroscience has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market. Which has preferable valuation & earnings, AEYE or AIFF? Audioeye has higher revenue and earnings than Firefly Neuroscience. Audioeye is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAudioeye$40.31M2.30-$3.08M-$0.29N/AFirefly Neuroscience$1.14M22.95-$19.88M-$0.63N/A Do analysts rate AEYE or AIFF? Audioeye presently has a consensus price target of $14.63, indicating a potential upside of 97.37%. Given Audioeye's stronger consensus rating and higher probable upside, analysts plainly believe Audioeye is more favorable than Firefly Neuroscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Audioeye 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryAudioeye beats Firefly Neuroscience on 14 of the 16 factors compared between the two stocks. Get Firefly Neuroscience News Delivered to You Automatically Sign up to receive the latest news and ratings for AIFF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AIFF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIFF vs. The Competition ExportMetricFirefly NeuroscienceTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$25.85M$3.69B$6.46B$12.11BDividend YieldN/A2.22%3.07%5.36%P/E Ratio-2.6745.3728.8025.31Price / Sales22.9549.61389.4971.06Price / CashN/A38.4122.9355.00Price / Book3.115.276.786.94Net Income-$19.88M$31.26M$204.43M$335.25M7 Day Performance-5.62%-2.80%-1.57%-1.38%1 Month Performance-23.98%-4.57%-3.71%0.09%1 Year Performance-49.09%28.79%31.35%32.51% Firefly Neuroscience Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIFFFirefly Neuroscience0.3113 of 5 stars$1.68+1.2%N/A-50.3%$25.85M$1.14MN/AN/AAnalyst UpgradeCANGCango2.8608 of 5 stars$0.55-5.3%$3.00+443.5%-88.5%$103.51M$688.08MN/A2,350Gap DownPODCPodcastOne1.4352 of 5 stars$3.56-2.5%N/A+91.0%$100.33M$52.12MN/AN/AUpcoming EarningsDHDefinitive Healthcare3.2608 of 5 stars$0.89-4.3%$2.77+212.2%-74.0%$97.78M$241.52MN/A970CCLDCareCloud4.1031 of 5 stars$2.12-5.4%$3.25+53.3%+10.4%$95.18M$120.50M19.273,650 Related Companies and Tools Related Companies CANG Competitors PODC Competitors DH Competitors CCLD Competitors AEYE Competitors TEAD Competitors CSPI Competitors SSTI Competitors EXFY Competitors AISP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIFF) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredRead this warning immediatelyPorter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the bigg...Porter & Company | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Firefly Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Firefly Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
